HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The α-cyclodextrin complex of the Moringa isothiocyanate suppresses lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells through Akt and p38 inhibition.

Abstract
In the last decades, a growing need to discover new compounds for the prevention and treatment of inflammatory diseases has led researchers to consider drugs derived from natural products as a valid option in the treatment of inflammation-associated disorders. The purpose of the present study was to investigate the anti-inflammatory effects of a new formulation of Moringa oleifera-derived 4-(α-L-rhamnopyranosyloxy)benzyl isothiocyanate as a complex with alpha-cyclodextrin (moringin + α-CD) on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells, a common model used for inflammation studies. In buffered/aqueous solution, the moringin + α-CD complex has enhanced the water solubility and stability of this isothiocyanate by forming a stable inclusion system. Our results showed that moringin + α-CD inhibits the production of inflammatory mediators in LPS-stimulated macrophages by down-regulation of pro-inflammatory cytokines (TNF-α and IL-1β), by preventing IκB-α phosphorylation, translocation of the nuclear factor-κB (NF-κB), and also via the suppression of Akt and p38 phosphorylation. In addition, as a consequence of upstream inhibition of the inflammatory pathway following treatment with moringin + α-CD, the modulation of the oxidative stress (results focused on the expression of iNOS and nitrotyrosine) and apoptotic pathway (Bax and Bcl-2) was demonstrated. Therefore, moringin + α-CD appears to be a new relevant helpful tool to use in clinical practice for inflammation-associated disorders.
AuthorsSabrina Giacoppo, Thangavelu Soundara Rajan, Renato Iori, Patrick Rollin, Placido Bramanti, Emanuela Mazzon
JournalInflammation research : official journal of the European Histamine Research Society ... [et al.] (Inflamm Res) Vol. 66 Issue 6 Pg. 487-503 (Jun 2017) ISSN: 1420-908X [Electronic] Switzerland
PMID28289752 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • IL1B protein, mouse
  • Interleukin-1beta
  • Isothiocyanates
  • Lipopolysaccharides
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • alpha-Cyclodextrins
  • moringin
  • NF-KappaB Inhibitor alpha
  • Proto-Oncogene Proteins c-akt
  • p38 Mitogen-Activated Protein Kinases
  • alpha-cyclodextrin
Topics
  • Animals
  • Anti-Inflammatory Agents (chemistry, pharmacology)
  • Inflammation (metabolism)
  • Interleukin-1beta (metabolism)
  • Isothiocyanates (chemistry, pharmacology)
  • Lipopolysaccharides
  • Mice
  • Moringa
  • NF-KappaB Inhibitor alpha (metabolism)
  • NF-kappa B (metabolism)
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors)
  • RAW 264.7 Cells
  • Tumor Necrosis Factor-alpha (metabolism)
  • alpha-Cyclodextrins (chemistry, pharmacology)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: